Microbiology News and Research

RSS

New approach to treating hepatitis C virus

Last year Peter Sarnow, PhD, professor of microbiology and immunology at the Stanford University School of Medicine, identified a previously unknown mechanism that the hepatitis C virus uses to replicate, yielding a promising new approach to combating the disease-causing virus.

10 Apr 2006

Mass spectrometry could aid biodefense in rapidly detecting dangerous pathogens

Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.

10 Apr 2006

Link between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor

A 37-year-old-mother, who gave birth to a low-weight preemie at 24 weeks, exhibited the first-found link in a human between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor.

6 Apr 2006

Breakthrough in search for new anti-malarial drugs

Scientists at Drexel University College of Medicine in Philadelphia have made a significant discovery in the fight against malaria. Drexel researchers, along with a research group at the University of Washington, have determined a critical molecular structure of the cellular motor that allows the malaria parasite to invade human cells.

4 Apr 2006

Clear evidence that elephantiasis can be eliminated

Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).

28 Mar 2006

Egyptian program to eliminate elephantiasis successful

Organizers of a 20-year global effort to eliminate a parasitic infection that is a leading cause of disability have an early victory to savor: a five-year Egyptian elimination campaign has mostly succeeded, according to a new report in the March 25 issue of The Lancet.

28 Mar 2006

Researchers find compound 10 times more effective than isoniazid, the leading anti-tuberculosis drug

Researchers at the Albert Einstein College of Medicine of Yeshiva University have synthesized chemicals that are up to 10 times more effective than isoniazid, the leading anti-tuberculosis drug.

28 Mar 2006

Swedish scientists move closer to a cancer vaccine

Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours. Although the results are so far based on animal experiments, they point to new methods of treating metastases.

21 Mar 2006

New discovery explains how a common gene variant may increase cancer risks

Roughly 15 percent of the population carries a gene variant that may increase the risk of developing cancer. The cause of this increased risk has been unknown until now. But now a research team at Stockholm University in Sweden can explain why.

21 Mar 2006

Novel vaccine approach to listeria - potential protection against other intracellular bacterial pathogens

When bacterial pathogens attack the surface of a cell, vaccine-induced antibodies can mount a formidable defense and fend off the bad bugs.

21 Mar 2006

Movement routes key to predicting spread of infectious diseases

Knowledge of 'movement routes' is the key to predicting the pattern of spread of infectious diseases of humans, and similar data could be crucial to understand animal disease risks, says team from the University of Edinburgh.

20 Mar 2006

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

A drug used to treat lymphoma, rheumatoid arthritis and other immune disorders may enable newly-diagnosed type 1 diabetics to save some of their pancreas function and thereby reduce their susceptibility to long-term complications.

20 Mar 2006

New tools in the fight against pneumococci

New tools in the fight against pneumococci - the bugs targeted by vaccines recently announced by the Department of Health - are described by a team led by scientists from the Wellcome Trust Sanger Institute.

13 Mar 2006

Scientists create a mosquito resistant to Type 2 dengue fever virus

Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.

9 Mar 2006

Dramatic increase in antibiotic-resistant staph infections

Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.

9 Mar 2006

Details of protein-cleaving complex key to microbe's survival may improve drug design

With the hope of designing more effective treatments for tuberculosis (TB), scientists from the U.S. Department of Energy's Brookhaven National Laboratory and collaborating institutions have published the first detailed reports on the biochemistry and structure of a protein-cleaving complex that is essential to the TB bacterium's survival.

9 Mar 2006

Researchers gain key insights into how different types of infection-fighting T-cells survive

T-cells, or lymphocytes, are the body's natural defense mechanism against infection, directly attacking foreign bodies such as bacteria and viruses.

7 Mar 2006

Genome signature tagging used to quickly identify and distinguish between pathogens and harmless microbes

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have developed a new, high-throughput technique for identifying the many species of microorganisms living in an unknown "microbial community."

6 Mar 2006

Scientists show how MRSA sidesteps hospital protection measures

The MRSA 'superbug' evades many of the measures introduced to combat its spread by infecting a common single-celled organism found almost everywhere in hospital wards, according to new research published in the journal Environmental Microbiology.

1 Mar 2006

Is persistent bacterial infection good for your health?

Bacteria are bad. Mothers and doctors, not to mention the cleaning product industry, repeatedly warn of their dangers. But a Stanford University School of Medicine microbiologist is raising the intriguing idea that persistent bacterial and viral infections have benefits.

27 Feb 2006

Microbiology News and Research

New approach to treating hepatitis C virus

Mass spectrometry could aid biodefense in rapidly detecting dangerous pathogens

Link between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor

Breakthrough in search for new anti-malarial drugs

Clear evidence that elephantiasis can be eliminated

Egyptian program to eliminate elephantiasis successful

Researchers find compound 10 times more effective than isoniazid, the leading anti-tuberculosis drug

Swedish scientists move closer to a cancer vaccine

New discovery explains how a common gene variant may increase cancer risks

Novel vaccine approach to listeria - potential protection against other intracellular bacterial pathogens

Movement routes key to predicting spread of infectious diseases

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

New tools in the fight against pneumococci

Scientists create a mosquito resistant to Type 2 dengue fever virus

Dramatic increase in antibiotic-resistant staph infections

Details of protein-cleaving complex key to microbe's survival may improve drug design

Researchers gain key insights into how different types of infection-fighting T-cells survive

Genome signature tagging used to quickly identify and distinguish between pathogens and harmless microbes

Scientists show how MRSA sidesteps hospital protection measures

Is persistent bacterial infection good for your health?

Microbiology eBook

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Latest Life Science News